Eqrx Inc (EQRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | EQRX | COLL | ELVN | ||
Company | Eqrx Inc | Collegium Pharma | Enliven Therapeutics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 2.39 | 37.80 | 21.81 | ||
High | 2.42 | 38.32 | 23.00 | ||
Low | 2.32 | 37.29 | 21.34 | ||
Last | 2.34 | 37.51 | 22.65 | ||
Change | -0.05 | unch | +1.66 | ||
% Change | -2.09% | unch | +7.91% | ||
Volume | 16,554,600 | 300,300 | 482,500 | ||
20-Day Average Volume | 4,083,095 | 328,470 | 544,720 | ||
Previous Close | 2.39 | 37.51 | 20.99 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 2.26 | 36.44 | 18.82 | ||
20-Day Raw Stochastic | 53.66% | 56.54% | 66.63% | ||
20-Day Relative Strength | 55.03% | 53.89% | 62.85% | ||
Weighted Alpha | -18.40 | +70.87 | -15.66 | ||
Today's Opinion | 96% Buy | 64% Buy | 100% Buy | ||
Previous Opinion | 96% Buy | 72% Buy | 100% Buy | ||
Last Month's Opinion | 24% Buy | 100% Buy | 88% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | +3.54% since 11/01/23 | +2.99% since 04/26/24 | +31.84% since 04/26/24 | ||
Low | 2.23 on 11/02/23 | 36.51 on 04/29/24 | 16.56 on 04/29/24 | ||
High | 2.63 on 11/03/23 | 38.47 on 05/01/24 | 23.00 on 05/03/24 | ||
1-Month | |||||
%Chg | +5.41% since 10/06/23 | -4.92% since 04/03/24 | +21.84% since 04/03/24 | ||
Low | 2.01 on 10/30/23 | 34.24 on 04/19/24 | 15.96 on 04/19/24 | ||
High | 2.63 on 11/03/23 | 40.49 on 04/04/24 | 26.00 on 04/11/24 | ||
3-Month | |||||
%Chg | +4.46% since 08/08/23 | +14.22% since 02/02/24 | +46.98% since 02/02/24 | ||
Low | 2.01 on 10/30/23 | 31.34 on 02/21/24 | 10.90 on 03/15/24 | ||
High | 2.63 on 11/03/23 | 40.95 on 03/28/24 | 26.00 on 04/11/24 | ||
6-Month | |||||
%Chg | +27.17% since 05/08/23 | +68.96% since 11/03/23 | +74.23% since 11/03/23 | ||
Low | 1.60 on 05/09/23 | 21.40 on 11/07/23 | 9.80 on 12/12/23 | ||
High | 2.63 on 11/03/23 | 40.95 on 03/28/24 | 26.00 on 04/11/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 1,140,551 | 1,226,802 | 1,064,663 | ||
Shares Outstanding, K | 487,415 | 32,706 | 47,005 | ||
Annual Sales | 0 | 566,770,000 | 0 | ||
Annual Net Income | -169,090,000 | 48,160,000 | -71,580,000 | ||
Last Quarter Sales | 0 | 149,750,000 | 0 | ||
Last Quarter Net Income | -72,960,000 | 31,940,000 | -19,370,000 | ||
60-Month Beta | 0.48 | 1.06 | 1.05 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.15 on 08/08/23 | 1.58 on 02/22/24 | -0.47 on 03/14/24 | ||
Latest Earnings Date | 11/09/23 | 05/09/24 | 05/09/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 7.55 | 0.00 |